Condition: Chronic Hepatitis B Virus · Sponsor: University Hospital, Limoges
Natural Killer (NK) and B cell immune responses occur during the early stages of infection and are essential to eradicate it. Yet, chronic hepatitis B (CHB) infection occurs because the antiviral immune response is insufficient. In both NK and B cell studies we will explore the genetic alterations that occur during the varied chronic stages of the disease. We believe that our findings will allow us to understand the molecular signature of NK and B cells in the context of HBV infection.
This description comes directly from the study's public registry record.
Paul CARRIER, MD · +335 55 05 80 22 · paul.carrier@chu-limoges.fr
Always discuss trial participation with your own doctor first.
| Centre d'Investigation Clinique | Limoges, France | Recruiting |
| Limoges University Hospital | Limoges, France | Recruiting |
| Hospice civils de Lyon | Lyon, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06853886